Videos

Joris
Van Houtven
UAntwerpen
UHasselt
VITO

Pathology-predicting proteins

Imagine being sick and simply being able to ask your body what's going on and what it needs to get better. Well, the proteins in our body can tell us that. But it takes a long time for us to understand what they're saying. With his tool, QCquan.net, bioinformatician Joris Van Houtven is determined to speed up that process!
Sarah Lima
Paralovo
UGent
VITO

How to ensure a healthy indoor air?

The COVID-19 pandemic has increased awareness about the importance of indoor ventilation. But measuring indoor air quality and ventilation rates often requires eco-unfriendly substances or complex and expensive equipment. Luckily, Sarah Lima Paralovo (Universiteit Gent - VITO) is developing a simple method to measure ventilation rates.
Anneleen
Remmerie
UGent
VIB

Fatty Liver Disease: the challenge for the Western world

One in six Belgians is obese and thus runs an increased risk of non-alcoholic fatty liver disease. This disease can affect the entire liver, in which case a liver transplant is needed to save the patient. Anneleen Remmerie (Ghent University - VIB) is looking for a way to combat the disease without the need for a new liver.
Esther
Hoste
UGent
VIB

Wound healing by liquorice?

Lots of people dislike these black sweets. But did you know that liquorice candy might well contain an ingredient to help cure wounds? Esther Hoste investigates whether an active compound found in the root of the liquorice plant can heal diabetic wounds 👉 🎥
Xenia
Geysemans
Arteveldehogeschool
UAntwerpen

Grieving at work: why is it so deadly quiet?

"We must learn to talk about death, also in the workplace". Xenia Geysemans investigates how employers can better support grieving employees. Currently, employers are often too absent. In this video, Xenia offers 4 concrete tips.
Ben
Rombaut
FWO
UHasselt

In search of the cause of Alzheimer's

In patients with Alzheimer's, microglia, the immune cells that protect our brains, suddenly start damaging the brain themselves by eating synapses. Ben Rombaut is trying to find out why this happens. In this way, he wants to help ensure that in our old age we can all stay on our toes.
Tim
Bomberna
FWO
UGent

Liver cancer: how do we get the medicines to the tumor?

As if developing a cancer drug is not difficult enough, you still have to successfully get that medicine to the tumor. Tim Bomberna (Ghent University) explains how computer simulations show us the way.
Sam
Vanherle
FWO
UHasselt

Is the key to MS therapy hidden in your body?

Immune cells serve to protect us. In multiple sclerosis, however, some immune cells just turn against the body and damage the nervous system. Sam Vanherle (Hasselt University) wants to detect these 'bad guys' in patients' blood and get them back on the right track. 💉
Assia
Tiane
FWO
UHasselt

Progressive MS: looking for the switch in our DNA in ons DNA

Did you know that there are already more than 15 medications for multiple sclerosis? Yet the more than 1 million progressive MS patients do not benefit from them, because these drugs only work in the early stages of the disease. Assia Tiane wants to help unravel the disease in order to improve the quality of life of progressive MS patients.
Hanne
Leysen
FWO
UAntwerpen

Communication as a source of medication with fewer side effects

How come medications have long leaflets with a whole list of possible side effects? That is what Hanne Leysen investigates. She looks at how signals are transmitted in our body, zooming in on cellular communication.
Marjolein
Orije
UAntwerpen

Protecting newborns by vaccinating the mummy

Marjolein Orije investigates whether vaccinating pregnant women helps to provide their child with the necessary antibodies against childhood diseases, such as whooping cough. Her research shows that vaccinating the pregnant mother also helps to boost the child's immune system, even if it is born prematurely.
Laurie
Freire Boullosa
UAntwerpen

Does an old rheumatism pill help against cancer?

It is a relatively new and promising path in cancer research: the reuse of old, non-cancer drugs. In her PhD, Laurie Freire Boullosa focuses on an old rheumatism pill and examines whether it can be used as a weapon against cancer.